NCT01502371 - A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223) | Biotech Hunter

Enrollment

583

Participants

Timeline

Start Date

January 25, 2012

Primary Completion Date

January 29, 2015

Study Completion Date

January 29, 2015

Conditions

Asthma

Interventions

DRUG

Mometasone Furoate (MF) Metered Dose Inhaler (MDI), 25 mcg

MF MDI 25 mcg (per inhalation), 2 puffs BID for 12 weeks

DRUG

Mometasone Furoate (MF) Metered Dose Inhaler (MDI), 50 mcg

MF MDI 50 mcg (per inhalation), 2 puffs BID for 12 weeks

DRUG

Mometasone Furoate (MF) Metered Dose Inhaler (MDI), 100 mcg

MF MDI 100 mcg (per inhalation), 2 puffs BID for 12 weeks

DRUG

Mometasone Furoate (MF) Dry Powder Inhaler (DPI), 100 mcg

MF DPI 100 mcg (per inhalation), 1 puff QD for 12 weeks

DRUG

Placebo Metered Dose Inhaler (MDI)

Placebo MDI, 2 puffs BID for 12 weeks

DRUG

Placebo Dry Powder Inhaler (DPI)

Placebo DPI, 1 puff QD for 12 weeks

All Listed Sponsors

lead

Organon and Co

INDUSTRY